{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:30:21Z","timestamp":1792024221788,"version":"4.4.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-15-00337"],"award-info":[{"award-number":["20-15-00337"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Cardiovascular pathologies maintain the leading position in mortality worldwide. Atherosclerosis is a chronic disease that can result in a variety of serious complications, such as myocardial infarction, stroke, and cardiovascular disease. Inflammation and lipid metabolism alterations play a crucial role in atherogenesis, but the details of relationships and causality of these fundamental processes remain not clear. The oxidation of LDL was considered the main atherogenic modification of LDL within the vascular wall for decades. However, recent investigations provided a growing body of evidence in support of the multiple LDL modification theory. It suggests that LDL particles undergo numerous modifications that change their size, density, and chemical properties within the blood flow and vascular wall. Oxidation is the last stage in this cascade resulting in the atherogenic properties. Moreover, recent investigations have discovered that oxLDL may have both anti-inflammatory and pro-inflammatory properties. Oxidized LDL can trigger inflammation through the activation of macrophages and other cells. After all, oxidized LDL is still a promising object for further investigations that have the potential to clarify the unknown parts of the atherogenic process. In this review, we discuss the role of oxLDL in atherosclerosis development on different levels.<\/jats:p>","DOI":"10.3389\/fphar.2020.613780","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T05:53:46Z","timestamp":1610344426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":334,"title":["Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Anastasia V.","family":"Poznyak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita G.","family":"Nikiforov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Markin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Kashirskikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika A.","family":"Myasoedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Gerasimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.20517\/2574-1209.2017.20","article-title":"Chemical composition of circulating native and desialylated low density lipoprotein: what is the difference?","volume":"1","author":"Alipov","year":"2017","journal-title":"Vessel Plus."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29240","DOI":"10.3402\/fnr.v59.29240","article-title":"LDL biochemical modifications: a link between atherosclerosis and aging","volume":"59","author":"Alique","year":"2015","journal-title":"Food Nutr. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","article-title":"Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes","volume":"34","author":"Bekkering","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1089\/ars.2013.5566","article-title":"Tetrahydrobiopterin in cardiovascular health and disease","volume":"20","author":"Bendall","year":"2014","journal-title":"Antioxid Redox Signal."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/01.atv.15.4.441","article-title":"Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL","volume":"15","author":"Bergmark","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"32512","DOI":"10.1074\/jbc.274.45.32512","article-title":"Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation","volume":"274","author":"Blair","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur. Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.bi.52.070183.001255","article-title":"Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis","volume":"52","author":"Brown","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fphar.2019.00463","article-title":"MiR-155 in the resolution of atherosclerosis","volume":"10","author":"Bruen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/biof.62","article-title":"CD40\/CD40L signaling and its implication in health and disease","volume":"35","author":"Chatzigeorgiou","year":"2009","journal-title":"Biofactors."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0123088","DOI":"10.1371\/journal.pone.0123088","article-title":"Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.12659\/msm.899852","article-title":"Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview","volume":"22","author":"Chen","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1242\/jcs.092767","article-title":"Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1","volume":"124","author":"Chen","year":"2011","journal-title":"J. Cell Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1159\/000443123","article-title":"LOX-1-mediated effects on vascular cells in atherosclerosis","volume":"38","author":"Chistiakov","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbabio.2004.03.008","article-title":"The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems","volume":"1657","author":"Cross","year":"2004","journal-title":"Biochim. Biophys. Acta."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1172\/JCI5897","article-title":"Disruption of the 12\/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice","volume":"103","author":"Cyrus","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/jcm9051402","article-title":"Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: the REGICOR study","volume":"9","author":"D\u00e9gano","year":"2020","journal-title":"J. Clin. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000329341","article-title":"Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats","volume":"82","author":"Dopp","year":"2011","journal-title":"Respiration."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5750","DOI":"10.4049\/jimmunol.1500615","article-title":"Coordinated regulation of miR-155 and miR-146a genes during induction of endotoxin tolerance in macrophages","volume":"195","author":"Doxaki","year":"2015","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/01.atv.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1089\/ars.2010.3502","article-title":"Critical role of the nitric oxide\/reactive oxygen species balance in endothelial progenitor dysfunction","volume":"15","author":"Fleissner","year":"2011","journal-title":"Antioxid Redox Signal."},{"key":"B25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1476-5381.2010.01196.x","article-title":"Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"164","author":"F\u00f6rstermann","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/ATVBAHA.116.307096","article-title":"Clarity on the isoform-specific roles of NADPH oxidases and NADPH oxidase-4 in atherosclerosis","volume":"36","author":"Fulton","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3389\/fphys.2018.00654","article-title":"Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis","volume":"9","author":"Gibson","year":"2018","journal-title":"Front. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.scitotenv.2018.02.312","article-title":"Silica nanoparticles promote oxLDL-induced macrophage lipid accumulation and apoptosis via endoplasmic reticulum stress signaling","author":"Guo","year":"2018","journal-title":"Sci. Total Environ."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1042\/BST0351147","article-title":"Biochemistry of oxidative stress","volume":"35","author":"Halliwell","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.118.033544","article-title":"Protease-activated receptor-2 plays a critical role in vascular inflammation and atherosclerosis in apolipoprotein E-deficient mice","volume":"138","author":"Hara","year":"2018","journal-title":"Circulation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1073\/pnas.78.10.6499","article-title":"Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins","volume":"78","author":"Henriksen","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0021-9150(79)90166-7","article-title":"LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture","volume":"32","author":"Hessler","year":"1979","journal-title":"Atherosclerosis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"205027","DOI":"10.6064\/2012\/205027","article-title":"Stress in obesity and associated metabolic and cardiovascular disorders","volume":"2012","author":"Holvoet","year":"2012","journal-title":"Scientifica (Cairo)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"H\u00f6rkk\u00f6","year":"1999","journal-title":"J. Clin. Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"961","DOI":"10.231\/JIM.0b013e3181ff46d7","article-title":"MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages","volume":"58","author":"Huang","year":"2010","journal-title":"J. Invest. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1159\/000453202","article-title":"The relationship of plasma miR-29a and oxidized low density lipoprotein with atherosclerosis","volume":"40","author":"Huang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"418313","DOI":"10.1155\/2011\/418313","article-title":"The dynamics of oxidized LDL during atherogenesis","volume":"2011","author":"Itabe","year":"2011","journal-title":"J. Lipids."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1273042","DOI":"10.1155\/2017\/1273042","article-title":"Small dense low-density lipoprotein as biomarker for atherosclerotic diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid Med. Cell Longev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1161\/01.atv.21.6.955","article-title":"Oxidized LDL modulates Bax\/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells","volume":"21","author":"Kataoka","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/antiox8070218","article-title":"LOX-1: regulation, signaling and its role in atherosclerosis","volume":"8","author":"Kattoor","year":"2019","journal-title":"Antioxidants (Basel)."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.33431","article-title":"Functional heterogeneity of NADPH oxidases in atherosclerotic and aneurysmal diseases","volume":"24","author":"Kigawa","year":"2017","journal-title":"J. Atheroscl. Thromb."},{"key":"B44","doi-asserted-by":"publisher","first-page":"9238","DOI":"10.1073\/pnas.85.23.9238","article-title":"Purification and characterization of a bovine acetyl low density lipoprotein receptor","volume":"85","author":"Kodama","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1089\/ars.2013.5607","article-title":"NADPH oxidases in vascular pathology","volume":"20","author":"Konior","year":"2014","journal-title":"Antioxid Redox Signal."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0162995","DOI":"10.1371\/journal.pone.0166537","article-title":"Deficiency of interleukin-15 confers resistance to obesity by diminishing inflammation and enhancing the thermogenic function of adipose tissues","volume":"11","author":"Lacraz","year":"2016","journal-title":"PLoS One."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.redox.2017.11.017","article-title":"Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages","volume":"15","author":"Lara-Guzm\u00e1n","year":"2018","journal-title":"Redox Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/01.cir.103.9.1282","article-title":"Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin","volume":"103","author":"Laursen","year":"2001","journal-title":"Circulation."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ddstr.2008.02.001","article-title":"Oxidative mechanisms and atherothrombotic cardiovascular disease","volume":"5","author":"Leopold","year":"2008","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/ars.2009.2733","article-title":"Oxidized LDL: diversity, patterns of recognition, and pathophysiology","volume":"13","author":"Levitan","year":"2010","journal-title":"Antioxid Redox Signal."},{"key":"B51","doi-asserted-by":"publisher","first-page":"21789","DOI":"10.1038\/srep21789","article-title":"MiR-155 acts as an anti-inflammatory factor in atherosclerosis-associated foam cell formation by repressing calcium-regulated heat stable protein 1","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B52","article-title":"The role of lipids and lipoproteins in atherosclerosis","volume-title":"Endotext [Internet].","author":"Linton","year":"2019"},{"key":"B53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","article-title":"Reduced macrophage apoptosis is associated with acceler atherosclerosis in low-density lipoprotein receptor-null mice","volume":"25","author":"Liu","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature."},{"key":"B55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbamcr.2010.09.004","article-title":"The iNOS\/Src\/FAK axis is critical in toll-like receptor-mediated cell motility in macrophages","volume":"1813","author":"Maa","year":"2011","journal-title":"Biochim. Biophys. Acta."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/IAI.72.9.4933-4939.2004","article-title":"Role of xanthine oxidoreductase as an antimicrobial agent","volume":"72","author":"Martin","year":"2004","journal-title":"Infect. Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1161\/01.ATV.0000229218.97976.43","article-title":"Scavenger receptors in atherosclerosis: beyond lipid uptake","volume":"26","author":"Moore","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/CIRCRESAHA.120.315942","article-title":"Vaccination strategies and immune modulation of atherosclerosis","volume":"126","author":"Nilsson","year":"2020","journal-title":"Circ. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/01.atv.0000033829.14012.18","article-title":"Oxidized LDL in carotid plaques and plasma associates with plaque instability","volume":"22","author":"Nishi","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jth.13925","article-title":"Oxidized low-density lipoprotein in inflammation-driven thrombosis","volume":"16","author":"Obermayer","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"B64","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MOL.0000000000000525","article-title":"LDL and foam cell formation as the basis of atherogenesis","volume":"29","author":"Orekhov","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/ijms21030817","article-title":"Role of phagocytosis in the pro-inflammatory response in LDL-induced foam cell formation a transcriptome analysis","volume":"21","author":"Orekhov","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2174\/0929867325666180320121137","article-title":"Modified and dysfunctional lipoproteins in atherosclerosis: effectors or biomarkers?","volume":"26","author":"Orekhov","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3390\/ijms21082716","article-title":"Signaling pathways potentially responsible for foam cell formation: cholesterol accumulation or inflammatory response-what is first?","volume":"21","author":"Orekhov","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1073\/pnas.86.4.1372","article-title":"Low density lipoprotein undergoes oxidative modification in vivo","volume":"86","author":"Palinski","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/cmi.2014.89","article-title":"NADPH oxidases: an overview from structure to innate immunity-associated pathologies","volume":"12","author":"Panday","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-60327-029-8_24","article-title":"Oxidized low-density lipoprotein","volume":"610","author":"Parthasarathy","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/ars.2008.2231","article-title":"Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins","volume":"11","author":"Pendyala","year":"2009","journal-title":"Antioxid Redox Signal."},{"key":"B72","doi-asserted-by":"publisher","first-page":"152786","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jacc.2017.04.010","article-title":"LOX-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation","volume":"69","author":"Pothineni","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/biology9030060","article-title":"Oxidative stress and antioxidants in atherosclerosis development and treatment","volume":"9","author":"Poznyak","year":"","journal-title":"Biology (Basel)."},{"key":"B75","doi-asserted-by":"publisher","first-page":"E205","DOI":"10.3390\/biomedicines8070205","article-title":"NLPR3 inflammasomes and their significance for atherosclerosis","volume":"8","author":"Poznyak","year":"","journal-title":"Biomedicines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ahj.2016.04.003","article-title":"Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: the Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)","volume":"177","author":"Ren","year":"2016","journal-title":"Am. Heart J."},{"key":"B77","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1615\/CritRevImmunol.2018026483","article-title":"How oxidized low-density lipoprotein activates inflammatory responses","volume":"38","author":"Rhoads","year":"2018","journal-title":"Crit. Rev. Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: a dominant, negative regulator of the innate immune response","volume":"5","author":"Saba","year":"2014","journal-title":"Front. Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"571846","DOI":"10.1155\/2012\/571846","article-title":"Immune response to lipoproteins in atherosclerosis","volume":"2012","author":"Samson","year":"2012","journal-title":"Cholesterol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/MJT.0b013e31819cdc9a","article-title":"Vitamin E and cardiovascular disease","volume":"17","author":"Saremi","year":"2010","journal-title":"Am. J. Therapeut."},{"key":"B81","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/hr.2011.39","article-title":"Oxidative stress and endothelial dysfunction in hypertension","volume":"34","author":"Schulz","year":"2011","journal-title":"Hypertens. Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2011.02.028","article-title":"Role for Nox1 NADPH oxidase in atherosclerosis","volume":"216","author":"Sheehan","year":"2011","journal-title":"Atherosclerosis"},{"key":"B83","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fimmu.2018.00747","article-title":"Antibodies reactive to commensal Streptococcus mitis show cross-reactivity with virulent Streptococcus pneumoniae serotypes","volume":"9","author":"Shekhar","year":"2018","journal-title":"Front. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"151894","DOI":"10.1016\/j.imbio.2019.12.003","article-title":"IL-15 and GM-CSF stimulated macrophages enhances phagocytic activity in ENU induced leukemic mice","volume":"4","author":"Singha","year":"2019","journal-title":"Immunobiology"},{"key":"B85","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1001\/jama.1990.03450230083034","article-title":"Lipoproteins and atherogenesis. Current concepts","volume":"264","author":"Steinberg","year":"1990","journal-title":"J. Am. Med. Assoc."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1161\/01.cir.0000014762.06201.06","article-title":"Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?","volume":"105","author":"Steinberg","year":"2002","journal-title":"Circulation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol. Rev."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.3390\/ijms20143561","article-title":"The atherogenic role of circulating modified lipids in atherosclerosis","volume":"20","author":"Summerhill","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11883-018-0737-7","article-title":"Antioxidants in the fight against atherosclerosis: is this a dead end?","volume":"20","author":"Toledo-Ibelles","year":"2018","journal-title":"Curr. Atheroscler. Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.freeradbiomed.2014.02.014","article-title":"OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators","volume":"70","author":"Valente","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"101026","DOI":"10.18632\/oncotarget.18197","article-title":"Let-7g suppresses both canonical and non-canonical NF-\u03baB pathways in macrophages leading to anti-atherosclerosis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"B93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s1050-1738(01)00111-6","article-title":"The oxidative modification hypothesis of atherosclerosis: does it hold for humans?","volume":"11","author":"Witztum","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00059-019-4790-y","article-title":"Immunity and inflammation in atherosclerosis","volume":"44","author":"Wolf","year":"2019","journal-title":"Herz."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/ijms18102034","article-title":"New insights into the role of inflammation in the pathogenesis of atherosclerosis","volume":"18","author":"Wu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2249.1995.tb06652.x","article-title":"Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL","volume":"102","author":"Wu","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","article-title":"LOX-1 in atherosclerosis: biological functions and pharmacological modifiers","volume":"70","author":"Xu","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fphys.2017.00600","article-title":"Oxidative stress-mediated atherosclerosis: mechanisms and therapies","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Physiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/CS20120304","article-title":"Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes","volume":"124","author":"Younis","year":"2013","journal-title":"Clin. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cells4020178","article-title":"Scavenger receptor structure and function in health and disease","volume":"4","author":"Zani","year":"2015","journal-title":"Cells"},{"key":"B101","doi-asserted-by":"publisher","first-page":"C340","DOI":"10.1152\/ajpcell.00249.2016","article-title":"oxLDL induces endothelial cell proliferation via Rho\/ROCK\/Akt\/p27kip1 signaling: opposite effects of oxLDL and cholesterol loading","volume":"313","author":"Zhang","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.613780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T09:41:29Z","timestamp":1610530889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.613780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":101,"alternative-id":["10.3389\/fphar.2020.613780"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.613780","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"article-number":"613780"}}